Drug intelligence / Profile preview

gallium-68 NOTA

Development stage
Unknown
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals
Administration
Intravenous, Oral
01

Overview

Gallium-68 NOTA (68Ga-NOTA) is a radiometal-chelator complex consisting of the positron-emitting radionuclide gallium-68 (^68Ga) coordinated by the macrocyclic chelating agent 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA). Due to the high thermodynamic stability and rapid labeling kinetics of the gallium-68 NOTA complex, it is widely utilized in radiochemistry and molecular imaging. Standalone 68Ga-NOTA has been investigated as a positron emission tomography (PET) tracer for the assessment of glomerular filtration rate (GFR) and gastric emptying. More commonly, NOTA serves as a bifunctional chelator conjugated to various targeting vectors (such as peptides, antibodies, or small molecules) to develop target-specific diagnostic radiopharmaceuticals (e.g., 68Ga-NOTA-hGZP, 68Ga-NOTA-AE105, and 68Ga-NOTA-exendin-4) for oncology and other clinical applications.

Other names
68Ga-NOTA[68Ga]Ga-NOTAgallium-68-NOTAgallium68-NOTAgallium 68-NOTA

Beyond the preview

Go deeper on gallium-68 NOTA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gallium-68 NOTA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call